Popular, Pharmacies

FTC Releases Controversial Interim Staff Report on PBMs’ Purported Impact on Drug Prices

Epstein Becker & Green on 8/16/2024

At an Open Commission Meeting on August 1, 2024, the Federal Trade Commission (FTC) presented a report prepared by its staff entitled Pharmacy Benefit Managers: The Powerful Middlemen Inflating Drug Costs and Squeezing Main...more

MoFo’s State + Local Government Enforcement Newsletter - August 2024

Morrison & Foerster LLP on 8/14/2024

Morrison Foerster’s State and Local Government Task Force is pleased to provide our bimonthly newsletter summarizing some of the most important and interesting developments from state attorneys general across the country and...more

Media Reports FTC Poised to Sue PBMs

Manatt, Phelps & Phillips, LLP on 7/22/2024

In the wake of the FTC’s July 9 vote to release an interim staff report on PBMs, several media outlets are reporting that the Commission is poised to sue large PBMs. The timing and nature of the litigation is unspecified,...more

Vital Signs: Digital Health Law Update | Spring 2024

Jones Day on 7/22/2024

Welcome to Vital Signs, a curated compilation of the latest legal and regulatory developments in digital health. Our lead article reports on recent developments in the U.S. Food and Drug Administration's ("FDA") regulatory...more

Court Rules in Favor of Manufacturers in 340B Drug Shipment Case

Manatt, Phelps & Phillips, LLP on 5/30/2024

On May 21, the U.S. Court of Appeals for the District of Columbia Circuit upheld the right of pharmaceutical manufacturers to place at least some restrictions on the shipment of 340B drugs to contract pharmacies of 340B...more

A Pharmacist's Guide To Prescription Drug Fraud Investigations

Hendershot Cowart P.C. on 3/22/2024

Prescription drug fraud has long been a focus for government regulators, but it has taken on new significance in the wake of America’s opioid crisis. The U.S. Department of Justice (DOJ), Department of Health and Human...more

Ransomware Attack Affects Millions, New York Hospitals and Pharmacies

Harris Beach PLLC on 3/7/2024

A ransomware attack on Change Healthcare, a technology company owned by UnitedHealth that touches one of every three U.S. patient records, has resulted in hospitals and pharmacies across New York facing a cash crunch. The...more

California Expands "No Pharmacist Left Alone" Pharmacy Staffing Requirements and Also Enacts New Safety Measures

Hinshaw & Culbertson - Health Care on 11/17/2023

Introduction - Pharmacy employees at some CVS and Walgreens stores, including pharmacists, technicians, and support staff, recently walked off of their jobs to protest insufficient staffing and dangerous workloads that they...more

False Claims Act Settlements to Know from Q2 2023

Bass, Berry & Sims PLC on 7/18/2023

There have been several noteworthy False Claims Act (FCA) settlements in the second quarter of 2023. Four of these settlements have come in over $20 million. This post summarizes key settlements of interest....more

Privacy Briefs: June 2023

Health Care Compliance Association (HCCA) on 6/9/2023

Privacy Briefs: June 2023 - Long-term care pharmacy network PharMerica disclosed a breach involving more than 5.8 million patients, making it the largest breach reported to the HHS Office for Civil Rights (OCR) in the last...more

U.S. House and Senate Committees Move Legislation to Reform Pharmacy Benefit Managers

McGuireWoods LLP on 5/25/2023

Both the House and Senate are considering multiple bipartisan bills concerning pharmacy benefit managers (PBMs), meaning action is likely this year. However, the timeline and path forward remain unclear, since the two bodies...more

[Webinar] First Annual Health Care Fraud Symposium - March 14th, 12:00 pm - 1:30 pm ET

Womble Bond Dickinson on 2/22/2023

Health Care fraud is a growing national issue. The National Heath Care Anti-Fraud Association estimates that health care fraud costs the nation about $68 billion annually — about 3 percent of the nation's $2.26 trillion in...more

Not What the Doctor Ordered: GoodRx to Pay $1.5 Million in FTC’s First Enforcement of the Health Breach Notification Rule

Wyrick Robbins Yates & Ponton LLP on 2/15/2023

The Federal Trade Commission earlier this month undertook an enforcement action against online pharmacy and telehealth provider GoodRx, in the latest example of the agency seriously pursuing its role as the nation’s de facto...more

AGG Food & Drug Newsletter - July 2021

Arnall Golden Gregory LLP on 7/26/2021

Arnall Golden Gregory LLP's Food & Drug Newsletter is a monthly update of legal and regulatory issues that affect the FDA-regulated community and highlights articles from members of our Food & Drug practice, as well as from...more

Report on Patient Privacy Volume 21, Number 6. Privacy Briefs: June 2021

Health Care Compliance Association (HCCA) on 6/14/2021

Report on Patient Privacy 21, no. 6 (June 2021) - Scripps Health in San Diego experienced what it called “an information technology security incident” from ransomware that was detected May 1, forcing some of its operations...more

U.S. Supreme Court Decision Supports State Regulation of Pharmacy Benefit Managers

Harris Beach PLLC on 2/3/2021

The U.S. Supreme Court’s recent unanimous decision clears the way for state regulation of Pharmacy Benefit Managers (“PBMs”). Rutledge v. Pharm. Care Mgmt. Ass’n, 141 S. Ct. 474 (2020). At issue before the High Court was...more

California Board of Pharmacy Approves "No Pharmacist Left Alone" Regulations for Retail Pharmacy Chains

Hinshaw & Culbertson - Health Care on 9/23/2020

In retail pharmacy chain stores, pharmacists are sometimes left alone for long periods of time. Pharmacists at such chains—which are also known as community pharmacies—have also had to perform a number of non-pharmacist...more

HHS guidance confers PREP Act immunity to pharmacists for certain COVID-19 tests

Hogan Lovells on 4/14/2020

On April 8, 2020, the Office of Assistant Secretary for Health (OASH), in the U.S. Department of Health and Human Services (HHS) issued Guidance for Licensed Pharmacists, COVID-19 Test, and Immunity Under the PREP...more

Financial Daily Dose 1.27.2020 | Top Story: Apple Stock Has Surged Over 2019, Consumers Divided on Future

Robins Kaplan LLP on 1/28/2020

Apple stock has surged over the past year, but consumers are divided over the stock price’s future. Apple’s software services and hardware products create an identity crisis that impacts the company’s future valuations....more

DTC Compounded Medications: A Treatment Option for a System in Need?

Troutman Pepper on 1/22/2020

We have all been there: An advertisement on television or a pop-up on Facebook beckons us to try the latest “visit-free,” “delivered to your door” treatment for a medical condition. Originally published in Dermatology Times...more

2019 Highlights in Canadian Life Sciences IP and Regulatory Law

Smart & Biggar on 1/10/2020

In 2019, Rx IP Update reported on a number of developments in Canadian life sciences IP and regulatory law. We review top developments below: 1) PMPRB: Amendments to Regulations will come into force July 1, 2020, court...more

FDA oversight looks shaky with drug recalls, rising vaping deaths and injuries

Patrick Malone & Associates P.C. | DC Injury... on 10/10/2019

Tens of millions of Americans may have been startled in recent days by the much-publicized pulling from the shelves of widely used drugs like ranitidine (aka Zantac), an over-the-counter heartburn remedy, and select lots of...more

Financial Daily Dose 10.1.2019 | Top Story: Credit Suisse COO Resigns in Wake of Corporate Spying Scandal

Robins Kaplan LLP on 10/1/2019

Top Tidjane Thiam ally Pierre-Olivier Bouee, Credit Suisse’s COO, has resigned in the wake of an internal probe finding that he “ordered the surveillance of the bank’s former wealth-management chief, Iqbal Khan, without...more

OIG says Part D contracts cost Medicare as much as $75 million in lost drug manufacturer rebates in one year

Bricker Graydon LLP on 7/10/2019

The Department of Health and Human Services (HHS) Office of Inspector General (OIG) released a report on July 1, 2019, finding that Medicare Part D contracts between Medicare Prescription Drug Plan sponsors and drug...more

Toward Uncharted Waters – The CVS-Aetna Merger

Orrick - Antitrust Watch on 6/12/2019

On June 4 – 5, 2019, Judge Richard J. Leon of the U.S. District Court for the District of Columbia held an extraordinary and unprecedented evidentiary hearing to decide whether to enter the proposed Final Judgment in U.S. v....more

Today's Popular Updates › Pharmacies

"My best business intelligence, in one easy email…"